These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 31678172)
61. Cell-type-specific eQTL of primary melanocytes facilitates identification of melanoma susceptibility genes. Zhang T; Choi J; Kovacs MA; Shi J; Xu M; ; ; Goldstein AM; Trower AJ; Bishop DT; Iles MM; Duffy DL; MacGregor S; Amundadottir LT; Law MH; Loftus SK; Pavan WJ; Brown KM Genome Res; 2018 Nov; 28(11):1621-1635. PubMed ID: 30333196 [TBL] [Abstract][Full Text] [Related]
62. Non-coding RNAs shuttled via exosomes reshape the hypoxic tumor microenvironment. Wang W; Han Y; Jo HA; Lee J; Song YS J Hematol Oncol; 2020 Jun; 13(1):67. PubMed ID: 32503591 [TBL] [Abstract][Full Text] [Related]
63. Liver kinase B1 restoration promotes exosome secretion and motility of lung cancer cells. Zhang C; Xiao X; Chen M; Aldharee H; Chen Y; Long W Oncol Rep; 2018 Jan; 39(1):376-382. PubMed ID: 29138862 [TBL] [Abstract][Full Text] [Related]
64. Exosomes Derived From Natural Killer Cells Exert Therapeutic Effect in Melanoma. Zhu L; Kalimuthu S; Gangadaran P; Oh JM; Lee HW; Baek SH; Jeong SY; Lee SW; Lee J; Ahn BC Theranostics; 2017; 7(10):2732-2745. PubMed ID: 28819459 [No Abstract] [Full Text] [Related]
65. CD9-positive Exosomes Derived from Cancer-associated Fibroblasts Might Inhibit the Proliferation of Malignant Melanoma Cells. Fujii N; Yashiro M; Hatano T; Fujikawa H; Motomura H Anticancer Res; 2023 Jan; 43(1):25-33. PubMed ID: 36585155 [TBL] [Abstract][Full Text] [Related]
66. Exosomal circPACRGL promotes progression of colorectal cancer via the miR-142-3p/miR-506-3p- TGF-β1 axis. Shang A; Gu C; Wang W; Wang X; Sun J; Zeng B; Chen C; Chang W; Ping Y; Ji P; Wu J; Quan W; Yao Y; Zhou Y; Sun Z; Li D Mol Cancer; 2020 Jul; 19(1):117. PubMed ID: 32713345 [TBL] [Abstract][Full Text] [Related]
67. Human mesenchymal stem cell derived exosomes inhibit the survival of human melanoma cells through modulating miR-138-5p/SOX4 pathway. Wang X; Cui Z; Zeng B; Qiong Z; Long Z Cancer Biomark; 2022; 34(4):533-543. PubMed ID: 35275523 [TBL] [Abstract][Full Text] [Related]
68. Co-Isolation of Cytokines and Exosomes: Implications for Immunomodulation Studies. Benjamin-Davalos S; Koroleva M; Allen CL; Ernstoff MS; Shu S Front Immunol; 2021; 12():638111. PubMed ID: 33968029 [TBL] [Abstract][Full Text] [Related]
69. Loss of expression of protein kinase C beta is a common phenomenon in human malignant melanoma: a result of transformation or differentiation? Gilhooly EM; Morse-Gaudio M; Bianchi L; Reinhart L; Rose DP; Connolly JM; Reed JA; Albino AP Melanoma Res; 2001 Aug; 11(4):355-69. PubMed ID: 11479424 [TBL] [Abstract][Full Text] [Related]
70. Characterization of Exosome-Related Gene Risk Model to Evaluate the Tumor Immune Microenvironment and Predict Prognosis in Triple-Negative Breast Cancer. Qiu P; Guo Q; Yao Q; Chen J; Lin J Front Immunol; 2021; 12():736030. PubMed ID: 34659224 [TBL] [Abstract][Full Text] [Related]
71. TRPM1 forms ion channels associated with melanin content in melanocytes. Oancea E; Vriens J; Brauchi S; Jun J; Splawski I; Clapham DE Sci Signal; 2009 May; 2(70):ra21. PubMed ID: 19436059 [TBL] [Abstract][Full Text] [Related]
72. Exosomal miR-22-3p from Mesenchymal Stem Cells Inhibits the Epithelial-Mesenchymal Transition (EMT) of Melanoma Cells by Regulating Chen Y; Fang Y; Li L; Luo H; Cao T; Tu B Front Biosci (Landmark Ed); 2022 Sep; 27(9):275. PubMed ID: 36224027 [TBL] [Abstract][Full Text] [Related]
73. Identification of differentially expressed messenger RNAs in human melanocytes and melanoma cells. Simon HG; Risse B; Jost M; Oppenheimer S; Kari C; Rodeck U Cancer Res; 1996 Jul; 56(13):3112-7. PubMed ID: 8674069 [TBL] [Abstract][Full Text] [Related]
74. Melanoma-derived exosomes: Versatile extracellular vesicles for diagnosis, metastasis, immune modulation, and treatment of melanoma. Alia Moosavian S; Hashemi M; Etemad L; Daneshmand S; Salmasi Z Int Immunopharmacol; 2022 Dec; 113(Pt A):109320. PubMed ID: 36274482 [TBL] [Abstract][Full Text] [Related]
75. Combining single-cell sequencing and spatial transcriptome sequencing to identify exosome-related features of glioblastoma and constructing a prognostic model to identify BARD1 as a potential therapeutic target for GBM patients. Zhao S; Wang Q; Ni K; Zhang P; Liu Y; Xie J; Ji W; Cheng C; Zhou Q Front Immunol; 2023; 14():1263329. PubMed ID: 37727789 [TBL] [Abstract][Full Text] [Related]
76. Immunoaffinity-Based Isolation of Melanoma Cell-Derived and T Cell-Derived Exosomes from Plasma of Melanoma Patients. Mondal SK; Whiteside TL Methods Mol Biol; 2021; 2265():305-321. PubMed ID: 33704724 [TBL] [Abstract][Full Text] [Related]
77. Identification of genes specifically regulated in human melanoma cells. Eberle J; Garbe C; Orfanos CE Arch Dermatol Res; 1995; 287(5):421-7. PubMed ID: 7625850 [TBL] [Abstract][Full Text] [Related]
78. Exosomes released by metabotropic glutamate receptor 1 (GRM1) expressing melanoma cells increase cell migration and invasiveness. Isola AL; Eddy K; Zembrzuski K; Goydos JS; Chen S Oncotarget; 2018 Jan; 9(1):1187-1199. PubMed ID: 29416686 [TBL] [Abstract][Full Text] [Related]
79. Recent Advances in Experimental Models of Breast Cancer Exosome Secretion, Characterization and Function. Pelissier Vatter FA; Lucotti S; Zhang H J Mammary Gland Biol Neoplasia; 2020 Dec; 25(4):305-317. PubMed ID: 33351162 [TBL] [Abstract][Full Text] [Related]
80. Immune suppressed tumor microenvironment by exosomes derived from gastric cancer cells via modulating immune functions. Liu J; Wu S; Zheng X; Zheng P; Fu Y; Wu C; Lu B; Ju J; Jiang J Sci Rep; 2020 Sep; 10(1):14749. PubMed ID: 32901082 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]